APLT 8.96 (+3.82%)
US03828A1016BiotechnologyBiotechnology

Applied Therapeutics (APLT) Stock Highlights

8.96 | +3.82%
2024-10-21 02:52:41
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.

Statistics

Range Today
8.68 9.02
Volume Today 728.4K
Range 1 Year
1.79 9.39
Volume 1 Year 418.69M
Range 3 Year
0.5 17.77
Volume 3 Year 616.69M
Range 10 Year
0.5 57.39
Volume 10 Year 697.46M

Highlights

Market Capitalization 1.03B (small)
Floating Shares 83.26M
Current Price 8.96
Price To Earnings -6.14
Price To Revenue -2.72K
Price To Book 14.22
Earnings Per Share -1.43
Payout Ratio 0%

Performance

Latest +3.82%
1 Month +37.63%
3 Months +58.02%
6 Months +86.67%
1 Year +243.3%
3 Years -47.51%
5 Years -22.15%
10 Years +6.67%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.